China Epigenetics Market Size & Outlook, 2023-2030
China epigenetics market, 2018-2030 (US$M)
Related Markets
China epigenetics market highlights
- The China epigenetics market generated a revenue of USD 958.5 million in 2023 and is expected to reach USD 2,609.6 million by 2030.
- The China market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Epigenetics market data book summary
| Market revenue in 2023 | USD 958.5 million |
| Market revenue in 2030 | USD 2,609.6 million |
| Growth rate | 15.4% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Kits, Instruments, Enzymes, Services |
| Key market players worldwide | Roche Holding AG, Thermo Fisher Scientific Inc, Eisai Co Ltd, Novartis AG ADR, Element Biosciences, Dovetail Genomics, Illumina Inc, Promega, Abcam PLC |
Other key industry trends
- In terms of revenue, China accounted for 6.6% of the global epigenetics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China epigenetics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,635.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Epigenetics Market Scope
Epigenetics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China epigenetics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to epigenetics market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 33.41% in 2023. Horizon Databook has segmented the China epigenetics market based on reagents, kits, instruments, enzymes, services covering the revenue growth of each sub-segment from 2018 to 2030.
The epigenetics market in China is rapidly growing due to the increasing demand for genome editing technologies. The country has become one of the leading players in the global biotech industry and has invested heavily in Research & Development (R&D) of epigenetics-based products.
This has attracted numerous domestic and foreign companies to invest in the epigenetics market in China. Moreover, the increasing need for sophisticated genetic treatments has spurred collaborations within the biotech industry.
The collaboration signifies a continuation of previous cooperation, aiming to enhance process development capabilities and current Good Manufacturing Practice (cGMP) management systems to further the advancement of CHINAGENE's gene therapy products in the dynamic landscape of genetic interventions.
Reasons to subscribe to China epigenetics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China epigenetics market databook
-
Our clientele includes a mix of epigenetics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China epigenetics market , including forecasts for subscribers. This country databook contains high-level insights into China epigenetics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China epigenetics market size, by product, 2018-2030 (US$M)
China Epigenetics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
